CytoMed Therapeutics Ltd

GDTC· Nasdaq

Since Oct 5, 2025

Transactions: 3
Purchases: 3
Sales: 0
Purchase value: $428.78K
Sale value: $0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Choo Chee KongDirector · 10% owner

4/AAmendment

Filed Jul 24, 2026Period of report Jul 14, 20260001493152-26-034654

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
PurchaseJul 20, 2026	ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED^F1	100,000	$1.50	$150.00K	630,324	Direct
PurchaseJul 14, 2026	ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED^F1	100,000	$1.50	$150.00K	530,324

Filing footnotes · 1

F1This Form 4/A amends the Form 4 originally filed on July 24, 2026 solely to correct the acquisition/disposition indicator in Column 4 of Table I from "D" to "A". No other changes have been made.

Open on SEC EDGAR

Choo Chee KongDirector · 10% owner

Filed Jun 15, 2026Period of report Jun 8, 20260001493152-26-028589

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
PurchaseMay 13, 2026	Ordinary Shares, no par value per share	112,000	$1.1498	$128.78K	430,324	Direct

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.